Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment.

Shinichiro KashiwagiGen TsujioYuka AsanoWataru GotoKoji TakadaKatsuyuki TakahashiTamami MorisakiHisakazu FujitaTsutomu TakashimaShuhei TomitaMasahiko OhsawaKosei HirakawaMasaichi Ohira

Published in: Journal of translational medicine (2018)

The effects of eribulin chemotherapy suggested that patients with progressive-type breast cancer that proliferates in a good iTME may have a good prognosis.

Keyphrases

metastatic breast cancer
locally advanced
papillary thyroid
multiple sclerosis
phase ii
squamous cell
squamous cell carcinoma
study protocol